RxDoctor Payments DataLook up a doctor →

Anjali Vaidya, MD

Advanced Heart Failure and Transplant Cardiology · Philadelphia, PANPI 1902969371

Payments from drug & device makers

$804,681in general payments, 2019–2025

Across 834 payments — averaging $964.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Actelion Pharmaceuticals US, Inc.$341K
  • United Therapeutics Corporation$190K
  • Bayer$154K
  • Merck$119K
  • Medtronic$360
  • Gilead$293
  • plus $117 from 1 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Actelion Pharmaceuticals US, Inc.352$341,018
United Therapeutics Corporation233$190,119
Bayer103$153,825
Merck128$118,950
Medtronic(2 entities)8$360
Gilead9$293
Janssen Scientific Affairs, LLC1$117

How this compares

$804,681 in reported general payments places this provider in the 90th percentile of 96 advanced heart failure and transplant cardiology providers in Pennsylvania.

See all advanced heart failure and transplant cardiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$33,656
Medicare patients
737
Services billed
1,620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other advanced heart failure and transplant cardiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →